BAM
AVDL

Belpointe Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Belpointe Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-128
Closed -$1.17K – 791
2023
Q1 		$1.17K Hold
128
– – ﹤0.01% 3447
2022
Q4 		$916 Buy
+128
New +$916 ﹤0.01% 3456